ArticleNature communications2026
Dynamic bond-driven encapsulation of enzymes in metal-organic frameworks beyond pore size constraints.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Immobilizing enzymes in a metal-organic framework (MOF) is an effective approach to improve their stability and reusability, but the small pore sizes of most MOFs exclude many industrially relevant enzymes. Here, we present a dynamic bond-mediated approach that enables enzyme encapsulation beyond pore size constraints. We constructed a series of mesoporous MOFs by integrating robust trivalent metal-carboxylate clusters with dynamic divalent metal-pyridyl units. Systematic variation of metal combinations and linker lengths precisely tunes the framework stability and dynamics, enabling reversible dissociation and reformation of metal-pyridyl bonds. These dynamic bonds function as molecular gates, permitting enzymes larger than the intrinsic pores to infiltrate while preserving framework integrity. The strategy was applied to encapsulate diverse enzymes, preserving high enzymatic activity and enhancing operational stability. Furthermore, it supports the co-immobilization of multi-enzyme systems, such as NahK and GlmU, for efficient cascade synthesis of high-value glycosylated donors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.